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1. General 
 All chemicals and solvents purchased from Sigma-Aldrich were used without further 
purification. Spectra of
 1
H NMR and 
13
C NMR were recorded using a Bruker DPX-400 in 
CDCl3 with TMS as internal reference. Splitting in the spectra are shown as s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br (broad). 
 Absorption spectrometry was performed using a Varian spectrophotometer. Steady 
state fluorescence measurements were conducted using a Varian Eclipse 
spectrofluorometer. Column chromatography of all products was performed using Merck 
Silica Gel 60 (particle size: 0.040–0.063 mm, 230–400 mesh ASTM). Reactions were 
monitored by thin layer chromatography using fluorescent coated aluminum sheets. 
Solvents used for spectroscopy experiments were spectrophotometric grade. Flourescence 
life time measurements were determined on a HORIBA Jobin Yvon fluorolog, FL-1057. 
HORIBA Scientific NanoLEDs at 490, 650 and 667 nm (pulse width < 250 ps) was used. 
The instrument response function was measured with an aqueous Ludox solution.  The 
decays were analyzed with a multi-exponential fitting function by iterative reconvolution 
and chi-square minimization. Mass spectra were recorded on Agilent Technologies 6530 
Accurate-Mass Q-TOF LC/MS.  
EET efficiency was determined using time-resolved approach with the formula below:  
 
   E = 1- F(DA)/F(D) 
 
where F(D) and F(DA) refer to fluorescence quantum yields donor (D) alone and donor 
as a part of Gate 2 respectively. Both measurements were performed in tetrahydrofuran.  
2. Singlet Oxygen Generation Experiment  
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Micelles of Gate 1 is prepared with Cremophor EL using the procedure in literature
1
 50 
mg Cremephor EL and Gate 1 (6 mg, 5 mol) were dissolved in 330 ml freshly distilled 
tetrahydrofuran. The solution was sonicated for 30 min, while the sonication water bath 
was kept below 35 
o
C. Then, THF was evaporated under reduced pressure and the 
remaining compounds were dissolved in water (5 ml). The suspension was filtered 
through 0.45 m PTFE filter. For each measurement micelles were prepared freshly. 
Concentrations of solutions of the compounds in micelles were predicted using their 
extinction coefficients in THF.   
1
O2 dependent degradation of water soluble trap, 2,2'-(anthracene-9,10-
diylbis(methylene)dimalonic acid was used to measure photodynamic activity since the 
absorption of this compound decreases indicating the generation of 
1
O2.
2
 Corresponsing 
reaction is given in Scheme S1.  
 
 
 
      Scheme S1. Reacion of trap molecule with 
1
O2.  
 
 
Since the water solubility of the anthracene-based trap is poor in water, samples were 
sonicated for 15 min to obtain clear solutions. Measurements were performed using 660 
nm LED and samples were irradiated with the light source from a 5 cm distance. All 
samples were aerated for 5 min prior to experiments. After incubation under dark for 15 
min, light was irradiated for 60 min and UV-Vis spectra were recorded at each 5 min 
intervals. Relative singlet oxygen efficiency was calculated by the percent decrease in 
trap absorbance at 378 nm within 60 min light irradiation period.  
 
3. Characterization of Integrated Logic Gate 
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Measurements were performed using 660 nm LED and samples were irradiated with the 
light source from a 2 cm distance. All samples were aerated for 5 min prior to 
experiments. D2O was used for the solutions since the lifetime of 
1
O2 in this solution is 
higher. Relative 
1
O2 generation efficiencies in different conditions were determined by 
taking the percent decrease of the trap absorption in a given time. Micellar constructs 
were prepared using 1:1 mole ratio of Gate 1 and 2. pH of the solutions were adjusted by 
using NaOH and HCl solutions to slightly acidic (around 6) and slightly basic (around 
7.5) values. The concentrations in micelle were determined by comparing the 
absorptivities of these compounds in THF solution.    
Samples were either kept under dark or irradiated with 660 nm light.  Fluorescence 
spectra are recorded for each 10 min intervals by exciting the samples at 520 nm.  
 
4. Additional Spectra  
 
Figure S1. pH titration curve of micellar Gate 1 in aqueous solution. 
 5 
 
Figure S2. Electronic absorption spectra of protonated and deprotonated micellar Gate 1 
in aqueous solution. 
 
Figure S3. Emission spectra of protonated (solid, black) and deprotonated (dashed, red) 
micellar Gate 1 in aqueous solution excited at 625 nm. 
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Figure S4. Change in the emission spectra of micellar Gate 1, 2 (0.75 M each) in acidic 
D2O under dark (50 min). The spectrum is recorded by excitation at 520 nm.   
 
Figure S5. Change in the emission spectra of micellar Gate 1, 2 (0.75 M each) in basic 
D2O under dark (50 min). The spectrum is recorded by excitation at 520 nm.   
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Figure S6. Change in the emission spectra of micellar Gate 1, 2 (0.75 M each) in basic 
D2O irradiated with 660 nm light (50 min). The spectrum is recorded by excitation at 520 
nm.   
 
Figure S7. Change in the excitation spectra of micellar Gate 1, 2 (0.75 M each) in 
acidic D2O before (black, solid) and after (red, dashed) irradiation with 660 nm light (50 
min). The spectrum is collected for emission at 670 nm.  
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Figure S8. Comparison of fluorescence enhancement of micellar Gate 2 (0.75 M) in the 
presence (black, square) and absence (red, dot) of photosensitizer (Gate 1, 0.75 M) in 
D2O. 
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Figure S9. Comparison of fractional increase in the emission of micellar Gate 1 and 2 
(0.75 M) in the presence of different combinations of GSH, singlet oxygen (acid) or 660 
nm light in D2O. The fluorescence spectra are recorded by excitation at 520 nm. 
 
 10 
5. Synthesis 
Compounds 3
3
, 8
4
, 10
5
, 12
3
 and 15
6
 are synthesized using procedures in literature.  
 
Synthesis of Compound 2: Hydroquinone (2 g, 18.2 mmol) was dissolved in 30 ml 
acetone. 5 equivalents of K2CO3 (12.6 g, 91 mmol) was added and the reaction mixture 
was refluxed for 30 min. Then, 3 equivalents of propargyl bromide (6. 48 g, 54.6 mmol) 
was added dropwise. The reaction mixture was refluxed for additional 12 h. Then, it was  
cooled to RT. Following the extraction with CHCl3, the organic layer was collected and 
dried over Na2SO4, followed by evaporation of the solvent under reduced pressure. Crude 
product was crystallized in hexanes to yield compound 2 (white solid, quantitative).  
1
H NMR (CDCl3, 400 MHz, ppm) 6.94 (s, 2H; ArH), 4.67 (d, 4H, J = 2.44 Hz; 
ArOCH2), 2.53 (t, 2H, J = 2.44 Hz; CCH). 
13
C NMR (CDCl3, 400 MHz, ppm) 152.4, 116.0, 78.8, 75.4, 56.5. 
 
Synthesis of Compound 4: CH2Cl2 (300 ml) was purged with Ar for 30 min. Compound 
3 (1.1 g, 4.45 mmol) and 2,4-dimethyl pyrrole (0.96 ml, 9.4 mmol) were added. The color 
of the solution turned into red after the addition of 3 drops of trifluoroacetic acid. The 
reaction mixture was stirred at room temperature for 12h. Then, tetrachloro-1,4-
benzoquinone (1.09 g, 4.45 mmol) was added and the reaction mixture was stirred at 
room temperature for 45 min. Then triethyl amine (5 ml) and boron trifluoride diethyl 
etherate (5 ml) were added sequencially. After stirring at room temperature for 30 min, it 
was extracted with water. Organic layer was dried with Na2SO4 and evaporated under 
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reduced pressure. The product was purified by silica gel column chromatography using 
CHCl3. Fraction containing compound 4 was collected then the solvent was removed 
under reduced pressure (400 mg, 0.86 mmol, 19% ). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.20 (d, 2H, J = 8.60 Hz; ArH), 7.01 (d, 2H, J = 8.64 
Hz; ArH), 6.00 (s, 2H; ArH),  4.05 (t, 2H, J = 6.44 Hz; OCH2), 3.31 (t, 2H, J = 6.80 Hz; 
NCH2), 2.58 (s, 6H; ArCH3), 1.86 (m, 2H; CH2), 1.70 (m, 2H; CH2), 1.55 (m, 4H; CH2), 
1.45 (s, 6H; ArCH3). 
13
C NMR (CDCl3, 400 MHz, ppm) 159.6, 155.2, 143.2, 141.9, 131.9, 129.2, 126.9, 
121.1, 115.1, 67.9, 51.4, 29.1, 28.8, 26.6, 25.7, 14.6, 14.5. 
 
Synthesis of Compound 5: Compound 4 (270 mg, 0.58 mmol) and I2 (368 mg, 1.45 
mmol) were dissolved in ethanol (100 ml). Iodic acid, HIO3 (204 mg, 1.16 mmol) was 
dissolved in a few drops of water and added into previous solution. The reaction mixture 
was stirred at 60
o
C for a few hours untill all reeactant was consumed. Then, saturated 
sodium thiosulfate solution was added (50 ml) and it was stirred at rrom temparature for 
additional 30 min. Then, it was extracted with CHCl3 and water. Organic layer was dried 
with Na2SO4 and evaporated under reduced pressure (415 mg, quantitative). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.22 (d, 2H, J = 8.68 Hz; ArH), 7.02 (d, 2H, J = 8.68 
Hz; ArH), 4.04 (t, 2H, J = 6.36 Hz; OCH2), 3.30 (t, 2H, J = 6.80 Hz; NCH2), 2.63 (s, 6H; 
ArCH3), 1.85 (m, 2H; CH2), 1.70 (m, 2H; CH2), 1.55 (m, 4H; CH2), 1.45 (s, 6H; ArCH3). 
13
C NMR (CDCl3, 400 MHz, ppm) 160.1, 156.6, 145.5, 141.6, 131.8, 129.1, 126.6, 
115.5, 85.8, 68.0, 51.4, 29.1, 28.8, 26.6, 25.7, 17.2, 16.0.  
HRMS (TOF-ESI): m/z calcd for C25H27BF2I2N5O
-:
 716.03716 [M-H]
-
, found: 716.06297 
[M-H]
-, Δ = 36.0 ppm. 
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Synthesis of Compound 6: Compound 2 (519 mg, 2.8 mmol) and compound 5 (200 mg, 
0.28 mmol) were dissolved in CHCl3 (3 ml) and THF (3 ml). Triethylamine (200 l) was 
added and the reaction was stirred for 5 min. Then, saturated solutions of CuSO4.5H2O 
(200 l) and sodium ascorbate (200 l) were added. Catalytic amount of Cu (0) was 
added. The reaction mixture was stirred for 12 h at room temperature. After the reaction 
was completed, it was extracted with CHCl3 and organic layer was evaporatd under 
reduced pressure. It was purified by silica gel column chromatography using CHCl3 as 
mobile phase. Fraction containing compound 6 was collected then the solvent was 
removed under reduced pressure (0.27 mmol, 241 mg, 96%). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.60 (s, 1H; ArH), 7.21 (d, 2H, J = 8.12 Hz; ArH), 
7.02 (d, 2H, J = 8.17 Hz; ArH), 6.93 (s, 4H; ArH), 5.16 (s, 2H; OCH2), 4.62 (d, 2H, J = 
1.52 Hz; OCH2), 4.48 (t, 2H, J = 7.12 Hz; NCH2), 4.01 (t, 2H, J = 6. 28 Hz; OCH2), 2.63 
(s, 6H; ArCH3), 2.02 (t, 1H, J = 1.40 Hz; CH), 1.96 (m, 2H, CH2), 1.82 (m, 2H, CH2), 
1.55 (m, 2H, CH2), 1.44 (s, m, 6H + 2H, ArCH3 + CH2).   
13
C NMR (CDCl3, 400 MHz, ppm) 160.0, 156.5, 153.1, 152.1, 145.4, 144.4, 141.7, 
131.7, 129.1, 126.6, 122.5, 116.1, 115.8, 115.4, 78.8, 75.4, 67.9, 62.7, 56.5, 50.3, 30.2, 
29.0, 26.3, 25.6, 17.2, 16.0.  
HRMS (TOF-ESI): m/z calcd for C37H38BF2I2N5NaO3
+
: 926.1017 [M+Na]
+
, found: 
926.08227 [M+Na]
+, Δ = 20.98 ppm. 
 
Synthesis of Compound 8: 4-hydroxybenzaldehyde (1.22 g, 10 mmol) was dissolved in 
20 ml acetonitrile. Acetic acid (10 ml) and nitric acid (0.75 ml) were added and the 
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reaction was refluxed for 3h. Then, it was cooled to RT and extracted with EtOAc and 
water. Organic layer was collected and dried with Na2SO4, solvent was evaporated under 
reduced pressure. (9.1 mmol, 1.52 g, 91%). 
1
H NMR (CDCl3, 400 MHz, ppm) 11.05 (s, 1H; ArOH), 9.98 (s, 1H), 8.68 (s, 1H, ArH), 
8.17 (d, 1H, J = 8.61 Hz; ArH), 7.34 (d, 1H, J = 8.68 Hz; ArH). 
13
C NMR (CDCl3, 400 MHz, ppm) 188.7, 159.3, 136.4, 128.6, 126.2, 121.3, 115.7.  
 
Synthesis of Compound 9: Compound 6 (200 mg, 0.22 mmol) and 4-hydroxy-3-
nitrobenzaldehyde, compound 8 (110 mg, 0.66 mmol) were dissolved in benzene (20 ml). 
Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was 
refluxed using Dean Stark apparatus until all aldehyde was consumed. After the reaction 
was completed, it was extracted with CH2Cl2 and water. Organic layer was collected and 
dried with Na2SO4, evaporated under reduced pressure. The product was purified by 
silica gel column chromatography using EtOAc as mobile phase. After the impurities are 
eluted from the column, the mobile phase was changed to CH2Cl2/MeOH/AcOH (90/5/5; 
v/v). Fraction containing compound 9 was collected, then the solvent was removed under 
reduced pressure (0.15 mmol, 180 mg, 68%). 
1
H NMR (9 + AcOH: CDCl3, 400 MHz, ppm) 8.79 (s, 2H; ArH), 8.19 (d, 2H, J = 16.81 
Hz; ArH), 7.97 (d, 2H, J = 8.80 Hz; ArH), 7.60 (d + s, 2H + 1H, J = 16.65 Hz; ArH), 7.23 
(d, 2H, J = 8.80 Hz; ArH), 7.19 (d, 2H, J = 7.44 Hz; ArH), 7.05 (d, 2H, J = 8.24 Hz; ArH), 
6.93 (s, 4H; ArH), 5.20 (s, 2H; OCH2), 4.64 (s, 2H; OCH2), 4.41 (t, 2H, J = 7.12 Hz; 
NCH2), 4.05 (t, 2H, J = 5.84 Hz; OCH2), 2.52 (s, 1H; CH), 1.85 (m, 2H, CH2), 1.60-1.40 
(m, 12H, CH2 + ArCH3).  
13
C NMR cannot be recorded due to poor solubility.   
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HRMS (TOF-ESI): m/z calcd for C51H43BF2I2N7O9- 1200.1278 [M-H]
-
, found: 
1200.13078 [M-H]
-, Δ = 2.48 ppm. 
 
Synthesis of Compound 11: 4-hydroxybenzaldehyde (1.23 g, 10 mmol) and compound 
10 (4.8 g, 15 mmol) were dissolved in 50 ml acetonitrile. K2CO3 (3.2 g, 22.4 mmol) and a 
few crystals of benzo-18-crown-6 were added. The reaction was refluxed until all 4-
hydroxybenzaldehyde was consumed. The solvent was evaporated in vacuo, extracted 
with water and CH2Cl2. Organic layer was dried with Na2SO4 and evaporated under 
reduced pressure. The product was purified by silica gel column chromatography using 
CH2Cl2/Hexane (75:25, v/v). Fraction containing compound 11 was collected then the 
solvent was removed under reduced pressure (2.1 g, 7.8 mmol, 78%). 
1
H NMR (CDCl3, 400 MHz, ppm) 9.80 (s, 1H), 7.75 (d, J=7.42 Hz, 2H, ArH), 6.94 (d, 
J=7.81 Hz, 2H, ArH), 4.13 (m, 2H; OCH2), 3.80 (m, 2H; OCH2), 3.70-3.40 (m, 8H; 
OCH2), 3.27 (s, 3H, OCH3). 
13
C NMR (CDCl3, 400 MHz, ppm) 190.8, 163.9, 131.9, 130.1, 114.9, 71.9, 70.9, 70.7, 
70.6, 69.5, 67.8, 59.0.  
 
Synthesis of Donor Compound, D: CH2Cl2 (300 ml) was purged with Ar for 30 min. 4-
(prop-2-ynyloxy) benzaldehyde 12 (1 g, 6.24 mmol) and 2,4-dimethyl-3-ethyl pyrrole 
(1.54 g, 1.7 ml, 12.6 mmol) were added. 3 drops of trifluoroacetic acid was added. The 
reaction mixture was stirred at room temperature for 12h. Then, tetrachloro-1,4-
benzoquinone (1.54 g, 6.24 mmol) was added and the reaction mixture was stirred at 
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room temperature for 45 min. Then triethyl amine (8 ml) and boron trifluoride diethyl 
etherate (8 ml) were added sequencially. After stirring at room temperature for 30 min, it 
was extracted with water. Organic layer was dried with Na2SO4 and evaporated under 
reduced pressure. The product was purified by silica gel column chromatography using 
CHCl3/Hexane (75:25, v/v) as mobile phase. Fraction containing D was collected then the 
solvent was removed under reduced pressure (400 mg, 0.92 mmol, 15%). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.21 (d, J = 8.72 Hz, 2H; ArH),  7.10 (d, J = 8.72 Hz, 
2H; ArH), 4.78 (d, J = 2. 40 Hz, 2H; OCH2), 2.57 (t, J = 2.44 Hz, 1H; CH), 2.55 (s, 6H; 
ArCH3),  2.32 (q, J = 7.56 Hz, 4H; ArCH2), 1.33 (s, 6H; ArCH3), 1.0 (t, J = 7.60 Hz, 6H; 
CH3).  
13
C NMR (CDCl3, 400 MHz, ppm) 158.0, 153.6, 140.0, 138.4, 132.8, 131.1, 129.8, 
128.9, 115.6, 78.1, 75.8, 56.0, 17.1, 14.6, 12.5, 11.8.  
 
Synthesis of Acceptor Compound A: Compound 11 (112 mg, 0.42 mmol) and compound 
D (70 mg, 0.17 mmol) were dissolved in benzene (40 ml). Piperidine (0.4 ml) and acetic 
acid (0.4 ml) were added. The reaction mixture was refluxed using Dean Stark apparatus 
until all BODIPY was consumed. After the reaction was completed, it was extracted with 
CH2Cl2 and water. Organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography using 
EtOAc/MeOH (98:2, v/v). Fraction containing compound A was collected then the 
solvent was removed under reduced pressure (90 mg, 0.1 mmol, 59%). 
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1
H NMR (CDCl3, 400 MHz, ppm) 7.68 (d, 2H, J = 16.77 Hz; ArH), 7.59 (d, 4H, J = 
8.72 Hz; ArCH3), 7.25-7.18 (d + d, 2H + 2H; ArH), 7.13 (d, 2H, J = 8.64 Hz; ArH), 6.97 
(d, 4H, J =8.72 Hz; ArH), 4.80 (d, 2H, J = 2.32 Hz; OCH2), 4.20 (t, 4H, J =4.68 Hz; 
OCH2), 3.80-3.60 (m, 8H; OCH2), 3.60 (m, 4H; OCH2), 3.40 (s, 6H; OCH3), 2.61 (q, 4H, 
J = 7.36 Hz; ArCH2), 1.40 (s, 6H; ArCH3), 1.15 (t, 6H, J = 7.40 Hz; CH3). 
13
C NMR (CDCl3, 400 MHz, ppm) 159.4, 158.0, 150.4, 138.7, 137.7, 135.3, 133.6, 
133.3, 129.9, 129.2, 128.7, 118.2, 115.6, 114.9, 78.1, 75.9, 72.0, 70.9, 70.7, 70.6, 69.7, 
67.6, 59.0, 56.1, 18.4, 14.1, 11.7.   
HRMS (TOF-ESI): m/z calcd for C54H65BF2N2NaO9
+
 957.46434 [M+Na]
+
; found: 
957.47300 [M+Na]+, Δ = 9.0 ppm. 
 
Synthesis of Compound 15: Argon was purged in EtOH (10 ml) for 15 min. NaOH (0.88 
g, 22 mmol) and 3-mercaptopropanol (2 g, 1.86 ml, 22 mmol) were added and the 
reaction was stirred at 0
o
C ice bath for 30 min while the flask was sealed. Then, cis-1,2-
dichloroethylene (1.04 g, 0.8 ml, 11 mmol) in degassed EtOH (1 ml) was added and the 
reaction mixture was refluxed for 18 h. After cooling to RT, it was extracted with 
petroleum ether and brine. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using EtOAc/Hexanes (50:50, v/v) as mpbile phase. Fraction containing 
compound 15 was collected then the solvent was removed under reduced pressure (2 g, 
9.6 mmol, 87%). 
1
H NMR (CDCl3, 400 MHz, ppm) 6.12 (s, 2H), 3.73 (t, J = 6.08 Hz, 4H; OCH2), 2.84 (t, 
j = 7.04 Hz, 4H; SCH2), 2.57 (b, 2H; OH), 1.88 (m, 4H; CH2).  
13
C NMR (CDCl3, 400 MHz, ppm) 123.9, 60.9, 32.7, 30.8.  
HRMS (TOF-ESI): m/z calcd for C8H16NaO2S2
+
: 231.04839 [M+Na]
+
; found: 231.05234 
[M+Na]
+, Δ = 17.0 ppm. 
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Synthesis of Compound 16: (Z)-3,3'-(ethene-1,2-diylbis(sulfanediyl))dipropan-1-ol, 
compound 15 (1.7 g, 8.16 mmol) was dissolved in 30 ml CH2Cl2 and 3.4 ml Et3N. In a 
dropper, p-toluene sulfonyl chloride (3.11 g, 16.32 mmol) was dissolved in CH2Cl2 10 ml 
and was added to the previous solution dropwise while the reaction mixture was being 
cooled with ice bath. It was stirred for 12h. After the extraction with water, organic layer 
was collected and dried with Na2SO4, evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3 as mobile phase. Fraction 
containing compound 16 was collected, then the solvent was removed under reduced 
pressure (white solid, 5.7 mmol, 2.95 g, 70%). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.80 (d, 4H, J = 8.48 Hz; ArH), 7.37 (d, 4H, J = 8.48 
Hz; ArH), 5.98 (s, 2H; ArH), 4.14 (t, 4H, J = 5.93 Hz; OCH2), 2.73 (t, 4H, J = 7.00 Hz; 
SCH2), 2.48 (s, 6H, ArCH3), 1.95 (m, 4H; CH2). 
13
C NMR (CDCl3, 400 MHz, ppm) 144.9, 132.9, 129.9, 127.9, 123.9, 68.3, 29.9, 29.6, 
21.7.  
HRMS (TOF-ESI): m/z calcd for C22H28NaO6S4
+ 
539.06609 [M+Na]
+
, found: 539.07170 
[M+Na]
+, Δ = 10.0 ppm. 
 
Synthesis of Compound 17: Compound 16 (200 mg, 0.38 mmol) was dissolved in 10 ml 
DMSO and sodium azide (247 mg, 3.8 mmol) was added to the reaction mixture. It was 
stirred 2h at 60 oC. After cooling to RT, it was extracted with EtOAc and brine. Organic 
layer was collected and dried with Na2SO4, evaporated under reduced pressure. (yellow 
oil, 3.8 mmol, 98 mg quantitative). 
1
H NMR (CDCl3, 400 MHz, ppm) 6.10 (s, 2H), 3.45 (t, J = 6.57 Hz, 4H; NCH2), 2.81 (t, 
j = 6.96 Hz, 4H; SCH2), 1.89 (m, 4H; CH2). 
13
C NMR (CDCl3, 400 MHz, ppm) 49.9, 37.6.   
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Synthesis of Compound 18: Compound D (80 mg, 184 mol) and compound 17 (476 mg, 
1.84 mmol) were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Flask was covered with 
aluminium folio to avoid light and Ar was purged for 15 min. Saturated solutions of 
CuSO4.5H2O (100 l) and sodium ascorbate (100 l) were added. Catalytic amount of Cu 
(0) was added. The reaction mixture was stirred for 12 h at room temperature. After the 
reaction was completed, it was extracted with CH2Cl2 and water. Organic layer was 
collected and dried with Na2SO4, evaporated under reduced pressure. The product was 
purified by silica gel column chromatography using EtOAc/Hexanes (50/50; v/v) as 
mobile phase. Fraction containing compound 18 was collected, then the solvent was 
removed under reduced pressure (94 mol, 65 mg, 51%). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.71 (s, 1H; ArH), 7.20 (d, J = 8.72 Hz, 2H; ArH), 
7.12 (d, J = 8.56 Hz, 2H; ArH), 6.15 (d, J = 8.32 Hz, 1H; CH), 6.06 (d, J = 8.37 Hz, 1H; 
CH), 5.26 (s, 2H, OCH2), 4.55 (t, J = 6.76 Hz, 2H; NCH2), 3.46 (t, J = 6.53 Hz, 2H; 
NCH2),  2.84 (t, J = 6.97 Hz, 2H; SCH2), 2.75 (t, J = 6.76 Hz, 2H; SCH2), 2.53 (s, 6H; 
ArCH3), 2.30 (m, 2H + 4H; CH2 + ArCH2), 1.82 (m, 2H; CH2), 1.33 (s, 6H; ArCH3), 1.0 
(t, J = 7.49 Hz, 6H; CH3). 
13
C NMR (CDCl3, 400 MHz, ppm) 158.7, 153.6, 143.7, 140.0, 138.4, 132.7, 131.1, 
129.6, 128.5, 127.0, 125.4, 123.2, 122.7, 115.3, 62.1, 49.6, 48.4, 31.1, 30.7, 30.2, 29.4, 
17.1, 14.6, 12.5, 11.8.  
HRMS (TOF-ESI): m/z calcd for C34H43BF2N8NaOS2
+
 715.29546 [M+Na]
+
, found: 
715.30182 [M+Na]
+, Δ = 8.89 ppm. 
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Synthesis of Gate 2: Compound 18 (30 mg, 43 mol) and compound A (35 mg, 37 mol) 
were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Flask was covered with aluminium 
folio to avoid light and Ar was purged for 15 min. Saturated solutions of CuSO4.5H2O 
(100 l) and sodium ascorbate (100 l) were added. Catalytic amount of Cu (0) was 
added. The reaction mixture was stirred for 12 h at room temperature. After the reaction 
was completed, it was extracted with CH2Cl2 and water. Organic layer was collected and 
dried with Na2SO4, evaporated under reduced pressure. The product was purified by 
silica gel column chromatography using EtOAc/MeOH (90/10; v/v) as mobile phase. 
Fraction containing Gate 2 was collected, then the solvent was removed under reduced 
pressure (25 mol, 40 mg, 68%). 
1
H NMR (CDCl3, 400 MHz, ppm) 7.75-7.65 (s+ s+ d, 1H + 1H + 2H; ArH), 7.58 (d, J 
= 8.80 Hz, 4H; ArH), 7.25-7.15 (d + d + d, 2H + 2H + 2H; ArH), 7.15-7.08 (d + d, 2H + 
2H; ArH), 6.96 (d, J = 8.76 Hz, 2H; ArH), 6.11 (s, 2H; CH), 5.29 (s, 2H; OCH2), 5.27 (s, 
2H; OCH2), 4.55 (m, 2H + 2H; NCH2), 4.20 (t, J = 5.0 Hz, 4H, OCH2), 3.90 (m, 4H; 
OCH2), 3.78 (m, 4H; OCH2), 3.72-3.60 (m, 8H; OCH2), 3.59 (m, 4H; OCH2), 3.40 (s, 6H; 
OCH3), 2.77 (m, 4H, SCH2), 2.61 (m, 4H; CH2), 2.53 (s, 6H; ArCH3), 2.30 (m, 4H + 4H; 
ArCH2), 1.38 (s, 6H; ArCH3), 1.34 (s, 6H; ArCH3), 1.17 (t, J = 7.36 Hz, 6H; CH3), 1.00 (t, 
J = 7.60 Hz, 6H; CH3). 
13
C NMR (CDCl3, 400 MHz, ppm) 159.4, 158.7, 153.6, 150.4, 143.8, 140.0, 138.7, 
138.4, 137.7, 135.4, 133.6, 133.2, 132.7, 130.5, 130.0, 129.6, 128.9, 128.7, 128.6. 
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